Methods for the Inactivation of Mycobacterium tuberculosis: a Systematic Review of the Literature.
Journal
International journal of mycobacteriology
ISSN: 2212-554X
Titre abrégé: Int J Mycobacteriol
Pays: India
ID NLM: 101615660
Informations de publication
Date de publication:
01 Jul 2024
01 Jul 2024
Historique:
received:
23
03
2024
accepted:
25
06
2024
medline:
15
9
2024
pubmed:
15
9
2024
entrez:
15
9
2024
Statut:
ppublish
Résumé
To systematize published laboratory methods to inactivate Mycobacterium tuberculosis (MTB) and to describe their effectiveness. We carried out a review of the scientific literature to identify the publications that reported methods for the inactivation of MTB, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations. The search addressed inactivation methodologies used in Public health laboratories for the treatment of biological material and only included studies reporting the efficacy of the method. The database used were PubMed (National Library of Medicine) and LILACS (Latin American and Caribbean Literature in Health Sciences). We evaluated the quality of the studies with the JBI (Joanna Briggs Institute) Critical Instrument Appraisal Checklist. We included 14 publications meeting the established inclusion and exclusion criteria. These 14 studies actually described a total of 35 inactivation methods. Most of them combined heat treatment with some chemical or enzymatic agent, and there were very few applying a single strategy. Twenty-four (68.57%) methods demonstrated significant efficacy in inactivating MTB. The systematic review identified 35 methods of inactivation of MTB, published in 14 studies. Most of the methods combined physical treatment techniques, especially heat, with chemical and/or enzymatic treatment techniques, obtaining mostly good results in preventing the reproduction of the microorganism. PROSPERO (International Prospective Register of Ongoing Systematic Reviews) (Code CRD42024503621).
Identifiants
pubmed: 39277884
doi: 10.4103/ijmy.ijmy_49_24
pii: 01929415-202413030-00002
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
237-246Informations de copyright
Copyright © 2024 Copyright: © 2024 International Journal of Mycobacteriology.
Références
Watkins J. Inactivation of Mycobacterium tuberculosis for Safe Use Outside of the BSL-3 Laboratory; 2020. Available from: https://www.proquest.com/openview/8bf71406ed6947ceed413b9c593ce884/1?pq-origsite=gscholar&cbl=18750&diss=y. [Last accessed on 2023 Nov 13].
Mann BC, Jacobson KR, Ghebrekristos Y, Warren RM, Farhat MR. Assessment and validation of enrichment and target capture approaches to improve Mycobacterium tuberculosis WGS from direct patient samples. J Clin Microbiol 2023;61:e0038223.
Lucas M, Ryan JM, Watkins J, Early K, Kruh-Garcia NA, Mehaffy C, et al. Extraction and separation of mycobacterial proteins. Methods Mol Biol 2021;2314:77-107.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg 2010;8:336-41.
Joanna Briggs Institute. JBI Critical Appraisal Tools. Available from: https://jbi.global/critical-appraisal-tools. [Last accessed on 2024 Feb 26].
Wang CH, Putri DU, Lee JC, Liao CC, Tsao ST, Hsiao AL, et al. Biosafety and proteome profiles of different heat inactivation methods for Mycobacterium tuberculosis. Microbiol Spectr 2021;9:e0071621.
Dunne WM Jr., Doing K, Miller E, Miller E, Moreno E, Baghli M, et al. Rapid inactivation of Mycobacterium and Nocardia species before identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2014;52:3654-9.
Qi C, Wallis C, Pahalawatta V, Frank A, Ramdin N, Viana R, et al. Evaluation of the efficiency of the sample inactivation reagent in the Abbott realtime MTB assay for inactivation of Mycobacterium tuberculosis. J Clin Microbiol 2015;53:3001-2.
Djelouagji Z, Drancourt M. Inactivation of cultured Mycobacterium tuberculosis organisms prior to DNA extraction. J Clin Microbiol 2006;44:1594-5.
Buijtels PC, Willemse-Erix HF, Petit PL, Endtz HP, Puppels GJ, Verbrugh HA, et al. Rapid identification of mycobacteria by Raman spectroscopy. J Clin Microbiol 2008;46:961-5.
Doig C, Seagar AL, Watt B, Forbes KJ. The efficacy of the heat killing of Mycobacterium tuberculosis. J Clin Pathol 2002;55:778-9.
Mtafya B, Qwaray P, John J, Sichone E, Shoo A, Gillespie SH, et al. A practical approach to render tuberculosis samples safe for application of tuberculosis molecular bacterial load assay in clinical settings without a biosafety level 3 laboratory. Tuberc Edinb Scotl 2023;138:102275.
Somerville W, Thibert L, Schwartzman K, Behr MA. Extraction of Mycobacterium tuberculosis DNA: A question of containment. J Clin Microbiol 2005;43:2996-7.
Billard-Pomares T, Bleibtreu A, Walewski V, Dziri S, Barbat A, Zahar JR, et al. Proposition of a safe Mycobacterium tuberculosis complex denaturation method that does not compromise the integrity of DNA for whole-genome sequencing. Tuberc Edinb Scotl 2019;117:62-4.
Sabiiti W, Azam K, Esmeraldo E, Bhatt N, Rachow A, Gillespie SH. Heat inactivation renders sputum safe and preserves Mycobacterium tuberculosis RNA for downstream molecular tests. J Clin Microbiol 2019;57:e01778-18.
Chedore P, Th’ng C, Nolan DH, Churchwell GM, Sieffert DE, Hale YM, et al. Method for inactivating and fixing unstained smear preparations of Mycobacterium tuberculosis for improved laboratory safety. J Clin Microbiol 2002;40:4077-80.
Machen A, Kobayashi M, Connelly MR, Wang YF. Comparison of heat inactivation and cell disruption protocols for identification of mycobacteria from solid culture media by use of vitek matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2013;51:4226-9.
Walz A, Lukka PB, Pearce C, Creissen E, Braunstein M, Hickey AJ, et al. Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies. Tuberc Edinb Scotl 2019;117:52-5.
Blackwood KS, Burdz TV, Turenne CY, Sharma MK, Kabani AM, Wolfe JN. Viability testing of material derived from Mycobacterium tuberculosis prior to removal from a containment level-III laboratory as part of a laboratory risk assessment program. BMC Infect Dis 2005;5:4.
Agency for Toxic Substances and Disease Registry; 2024. Available from: https://www.atsdr.cdc.gov/index.html. [Last accessed on 2024 Mar 10].
da Silva EH, Lima E, Dos Santos TR, Padoveze MC. Prevalence and incidence of tuberculosis in health workers: A systematic review of the literature. Am J Infect Control 2022;50:820-7.
Harrington JM, Shannon HS. Incidence of tuberculosis, hepatitis, brucellosis, and shigellosis in British medical laboratory workers. Br Med J 1976;1:759-62.
World Health Organization. Operational Handbook on Tuberculosis. Module 1: Prevention – Infection Prevention and Control; 2023. Available from: https://iris.who.int/bitstream/handle/10665/372738/9789240078154-eng.pdf?sequence=1.[Last accessed on 2024 Feb 10].
Centers for Disease Control and Prevention. Guidance on the Inactivation or Removal of Select Agents and Toxins for Future Use; 2018.
Public Health Agency of Canada. Biosafety Directive for Mycobacterium tuberculosis Complex (MTBC); 2021. Available from: https://www.canada.ca/content/dam/phac-aspc/documents/services/laboratory-biosafety-biosecurity/biosafety-directives-advisories-notifications/biosafety-directive-mycobacterium-tuberculosis-complex-mtbc/MTBC-Directive-21Feb2017.pdf. [Last accessed on 2024 Feb 12].